← FDA Drug Approvals (Drugs@FDA)

LORAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2009-04-28

Drug application

FDA Application #

ANDA079244

Application type

Abbreviated New Drug Application (Generic)

Brand name

LORAZEPAM

Generic name

LORAZEPAM

Active ingredients

LORAZEPAM

Dosage form

CONCENTRATE

Route

ORAL

Marketing status

Discontinued

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2009-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown